Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) A study published in JAMA Ophthalmology in July 2024 indicates that patients with type 2 diabetes who are taking GLP-1 receptor agonists may be at an increased risk for developing a serious and debilitating condition known as Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Key points Key messages from the paper Incretin analogues (semaglutide, tirzepatide) provide effective glucose control in type 2 diabetes mellitus (T2DM) and major weight losses in people without diabetes
Celebrities and wealthy LA socialites from Elon Musk to Robbie Williams and, according to rumour, the Kardashians have turned to Ozempic off-label, i.e
This can happen due to various factors that need careful examination
Dissident West (@dissidentwest) May 10, 2026 Political and economic framing represented another highly engaging discussion category on X particularly around pharmaceutical dependency, healthcare economics and policy speculation
Discrepancies of more than 5% indicate either manufacturing quality issues or deliberate short-filling